Journal article icon

Journal article

Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study.

Abstract:

BACKGROUND: Antibodies against Haemophilus influenzae type b (Hib) and serogroup C Neisseria meningitidis (MenC) persist better to 3½ years of age after a 12-month booster dose of a combination Hib-MenC glycoconjugate vaccine (Hib-MenC-TT) in children primed in infancy with Hib-MenC-TT and diphtheria-tetanus-acellular-pertussis-inactivated poliovirus vaccine (DTaP-IPV) than in those who received a monovalent MenC-CRM197 and DTaP-IPV-Hib (also TT conjugated). Pertussis antibodies against fila...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


Expand authors...
Journal:
Pediatric infectious disease journal
Volume:
31
Issue:
10
Pages:
1069-1073
Publication date:
2012-10-01
DOI:
EISSN:
1532-0987
ISSN:
0891-3668
Source identifiers:
334768

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP